Luigi Mangione Expected To Plead Guilty In Federal Court, Report Says

Luigi Mangione, the 28-year-old accused of fatally shooting UnitedHealthcare CEO Brian Thompson in Manhattan in December 2024, is expected to plead guilty to federal stalking charges in a hearing scheduled for Friday, Aug. 14, 2026, according to multiple reports. The development, first cited by The New York Times and corroborated by other outlets, could avert a federal trial but leaves his separate state murder prosecution in limbo, with legal experts warning of complex procedural hurdles.

Mangione faces two federal charges of stalking resulting in death, each carrying a maximum sentence of life in prison. However, the Justice Department had previously sought the death penalty for murder and firearms charges, which were dismissed in January 2026. The dismissed charges had made Mangione eligible for capital punishment, but their removal eliminated that possibility in the federal case. A guilty plea would resolve the remaining federal charges and sidestep a trial originally set for January 2027.

Mangione’s legal team has not publicly confirmed the plea, and the terms remain undisclosed. The New York Times noted the discussions are “sensitive,” with the potential for the deal to collapse. If accepted, the plea could trigger a legal battle over double jeopardy, as Mangione’s attorneys aim to block his state trial by arguing that prosecuting him for the same act in New York violates constitutional protections against being tried twice for the same crime. However, New York law allows multiple prosecutions if the charges “contain an element which is not an element of the other,” a threshold prosecutors may seek to meet by emphasizing the distinct nature of state murder charges.

“It is incredibly complicated,” defense attorney Paul Shechtman told The New York Times earlier in August, highlighting the ambiguity of New York’s double jeopardy framework. State prosecutors, led by Manhattan District Attorney Alvin Bragg, have already dismissed terrorism charges against Mangione but maintain that second-degree murder—carrying a sentence of 25 years to life—remains a valid state offense. A state trial is scheduled to begin on Sept. 8, 2026, before Justice Gregory Carro.

The potential plea has drawn attention to the broader legal and public discourse surrounding Mangione’s case. The suspect, arrested in Pennsylvania in December 2024, was found with a manifesto criticizing corporate greed and the U.S. healthcare system. His case has become a focal point for debates over healthcare costs and legal accountability, with some segments of the public expressing sympathy for his stated grievances. However, prosecutors have emphasized the gravity of Thompson’s killing, a high-profile murder that sparked a nationwide manhunt.

Legal analysts suggest that a federal guilty plea might also allow Mangione to present mitigating factors to a judge, potentially reducing his sentence. TMZ founder Harvey Levin, a former attorney, speculated that the plea could involve a “guilty plea to murder,” though the exact charges remain unclear. New York criminal defense attorney James Kousouros noted that such a plea could “open the door to presenting mitigating circumstances” to avoid a life sentence.

The outcome of the plea discussions remains uncertain. Federal prosecutors, led by Jamie McDonald, have not disclosed the purpose of a scheduled court conference on Aug. 14, while Mangione’s attorneys have not responded to requests for comment. If the deal falls through, Mangione would still face a federal trial in January 2027 and a state trial in September 2026. The courts will ultimately determine whether the state case can proceed, with the possibility of a protracted legal showdown over jurisdiction and constitutional principles.

"What this opens the door to is that Mr. Mangione could, in federal court, present mitigating circumstances in order to convince the judge to give him a sentence less than a life sentence."

James Kousouros, New York criminal defense attorney, via fox5ny.com

"It is incredibly complicated," defense attorney Paul Shechtman told the Times earlier in August about New York’s law.

Paul Shechtman, defense attorney, via forbes.com